Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-16T19:58:58.091Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute citalopram administration may disrupt contextual information processing in healthy males

Published online by Cambridge University Press:  16 April 2020

S. Almeida ,
D.C. Glahn ,
S.V. Argyropoulos  and
S. Frangou
S. Almeida
Affiliation:
Section of Neurobiology of Psychosis (PO66), Institute of Psychiatry, King's College London, De Crespigny Park, LondonSE5 8AF, UK
D.C. Glahn
Affiliation:
Department of Psychiatry, Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Yale University School of Medicine, Whitehall Residence Building, IOL, Room 202, 200 Retreat avenue, Hartford CT06106, UK
S.V. Argyropoulos*
Affiliation:
Section of Neurobiology of Psychosis (PO66), Institute of Psychiatry, King's College London, De Crespigny Park, LondonSE5 8AF, UK
S. Frangou
Affiliation:
Section of Neurobiology of Psychosis (PO66), Institute of Psychiatry, King's College London, De Crespigny Park, LondonSE5 8AF, UK
*
*Corresponding author. Tel.: +44 207 848 0425; fax: +44 207 848 0903. E-mail address: [email protected] (S.V. Argyropoulos).
Get access

Abstract

Selective serotonin reuptake inhibitors (SSRI) are the most commonly prescribed antidepressants. It has been suggested however that SSRI administration may affect response inhibition and contextual processing but the available evidence is minimal. Therefore, the purpose of this study was to identify the effect size of acute (within 24 hours) and chronic (28 days) administration of the highly selective SSRI, Citalopram, compared to placebo on response inhibition (measured by the Degraded Symbol Continuous Performance Task [DS-CPT]) and contextual processing (assessed using a Delayed Non-Matching to Sample Task [DNMS]) in healthy males (n = 20) using a randomised double-blind design. We found no effect of Citalopram on participants’ performance on the DS-CPT which suggests either that SSRIs do not affect response inhibition or that this measure is insensitive to any potential disinhibition effects of SSRI. Acute, but not chronic, Citalopram administration was associated with a measurable decrement in the DNMS suggestive of a negative impact of SSRI administration on contextual processing at least during treatment initiation. These findings provide a useful guide for designing future studies in clinical populations.

Keywords

AntidepressantCitalopramResponse inhibitionContextual processing
Type
Original articles
Information
European Psychiatry , Volume 25 , Issue 2 , March 2010 , pp. 87 - 91
Copyright
Copyright © Elsevier Masson SAS 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aghajanian, G, Sanders-Bush, E.Serotonin. In: Davis, K, Charney, D, Coyle, J, Nemeroff, C, eds. Neuropsychopharmacology: The Fifth Generation of Progress: American College of Neuropsychopharmacology, PhiladelphiaLippincott/Williams & Wilkins;2002.Google Scholar
Anderson, I.M., Nutt, D.J., Deakin, J.F.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharm 2000; 14: 3–20.CrossRefGoogle ScholarPubMed
Araneda, R., Andrade, R.5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 1991; 40: 399–412.CrossRefGoogle ScholarPubMed
Baldessarini, R.J., Pompili, M., Tondo, L.Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry 2006; 63: 246–248.CrossRefGoogle ScholarPubMed
Baldwin, D.S., Anderson, I.M., Nutt, D.J., Bandelow, B., Bond, A., Davidson, J.R.et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharm 2005; 19: 567–596.CrossRefGoogle ScholarPubMed
Beck, A.T., Epstein, N., Brown, G., Steer, R.A.An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893–897.CrossRefGoogle ScholarPubMed
Beck, A.T., Steer, R.A.Beck Depression Inventory Manual San Antonio. Texas: Harcourt Brace Jovanovic; 1987.Google Scholar
Bersani, G., Grispini, A., Marini, S., Pasini, A., Valducci, M., Ciani, N.5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. Clin Neuropharm 1990; 13: 500–506.CrossRefGoogle ScholarPubMed
Campbell, S., Marriott, M., Nahmias, C., MacQueen, G.M.Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004; 161: 598–607.CrossRefGoogle ScholarPubMed
Cloninger, C.R.A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987; 44: 573–588.CrossRefGoogle ScholarPubMed
Glahn, D.C., Barrett, J., Bearden, C.E., Mintz, J., Green, M.F., Serap Monkul, E.et al. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychol Med 2006; 36: 1085–1095.CrossRefGoogle Scholar
Grunschlag, C.R., Haas, H.L., Stevens, D.R.5-HT inhibits lateral entorhinal cortical neurons of the rat in vitro by activation of potassium channel-coupled 5-HT1A receptors. Brain Res 1997; 770: 10–17.CrossRefGoogle ScholarPubMed
Gunnell, D., Saperia, J., Ashby, D.Selective serotonin reuptake inhibitors (SSRI) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005; 330: 385.CrossRefGoogle ScholarPubMed
Keilp, J.G., Sackeim, H.A., Brodsky, B.S., Oquendo, M.A., Malone, K.M., Mann, J.J.Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001; 158: 735–741.CrossRefGoogle ScholarPubMed
Meltzer, L.A., Yabaluri, R., Deisseroth, K.A role for circuit homeostasis in adult neurogenesis. Trends Neurosci 2005; 28: 653–660.CrossRefGoogle ScholarPubMed
Naudon, L., Hotte, M., Jay, T.M.Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology 2007; 191: 353–364.CrossRefGoogle ScholarPubMed
Nuechterlein, KH, Asarnow, RF.Degraded Stimulus Continuous Performance Test (DS-CPT): Program for IBM-Compatible Microcomputers. Version 8.11. Los Angeles CA;1999.Google Scholar
Nutt, D.J.Death and dependence: current controversies over the selective serotonin reuptake inhibitors. J Psychopharm 2003; 17: 355–364.CrossRefGoogle ScholarPubMed
Oquendo, M.A., Galfalvy, H., Russo, S., Ellis, S.P., Grunebaum, M.F., Burke, A.et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 2004; 161: 1433–1441.CrossRefGoogle ScholarPubMed
Patton, J.H., Stanford, M.S., Barratt, E.S.Factor structure of the Barratt impulsiveness scale. J Clinical Psychol 1995; 51: 768–774.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Sánchez, C., Hyttel, J.Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999; 19: 467–489.CrossRefGoogle ScholarPubMed
Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E.et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59(Suppl. 20): 22–33.Google ScholarPubMed
Spielberger, C.D., Gorsuch, R.L., Lushene, R., Vagg, P.R., Jacobs, G.A.Manual for the State-Trait Anxiety Inventory. Palo Alto. California: Consulting Psychologists’ Press; 1983.Google Scholar
Stafford, R., MacDonald, E., Finkelstein, S.National patterns of medication treatment for depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry 2001; 3: 232–235.CrossRefGoogle ScholarPubMed
Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G.et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008; 64: 293–301.CrossRefGoogle Scholar
Swann, A.C., Dougherty, D.M., Pazzaglia, P.J., Pham, M., Steinberg, J.L., Moeller, F.G.Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 2005; 162: 1680–1687.CrossRefGoogle ScholarPubMed
Winocur, G., Wojtowicz, J.M., Sekeres, M., Snyder, J.S., Wang, S.Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 2006; 16: 296–304.CrossRefGoogle ScholarPubMed
Winsauer, P.J., Moerschbaecher, J.M.Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys. Behav Pharmacol 2000; 11: 535–553.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.